|
|
|
|
Vol. 53, Issue 4, 766-771, April 1998
1-Adrenergic Receptor Activation:
Evidence for a Salt Bridge as the Initiating Process
Department of Molecular Cardiology, The Lerner Research Institute,
The Cleveland Clinic Foundation, Cleveland, Ohio 44195 (J.E.P., D.J.W.,
D.M.P.) and
Department of Pharmacology, College of Medicine, University
of Kentucky, Lexington, Kentucky 40536 (S.E.E., M.T.P.).
1-adrenergic receptor (AR) activation is thought to be
initiated by disruption of a constraining interhelical salt bridge (). Disruption of this salt bridge is
achieved through a competition for the aspartic acid residue in
transmembrane domain three by the protonated amine of the endogenous
ligand norepinephrine and a lysine residue in transmembrane domain
seven. To further test this hypothesis, we investigated the possibility that a simple amine could mimic an important functional group of the
endogenous ligand and break this
1-AR ionic constraint leading to agonism. Triethylamine (TEA) was able to generate
concentration-dependent increases of soluble inositol phosphates in
COS-1 cells transiently transfected with the hamster
1b-AR and in Rat-1 fibroblasts stably transfected with
the human
1a-AR subtype. TEA was also able to synergistically potentiate the second messenger production by weak
partial
1-AR agonists and this effect was fully
inhibited by the
1-AR antagonist prazosin. However, this
synergistic potentiation was not observed for full
1-AR
agonists. Instead, TEA caused a parallel rightward shift of the
dose-response curve, consistent with the properties of competitive
antagonism. TEA specifically bound to a single population of
1-ARs with a Ki of
28.7 ± 4.7 mM. In addition, the site of binding
by TEA to the
1-AR is at the conserved aspartic acid
residue in transmembrane domain three, which is part of the
constraining salt bridge. These results indicate a direct interaction
of TEA in the receptor agonist binding pocket that leads to a
disruption of the constraining salt bridge, thereby initiating
1-AR activation.
This article has been cited by other articles:
![]() |
J. E. Porter and D. M. Perez Influence of a Lysine 331 Counterion on the pKa of Aspartic Acid 125: Evidence for a Salt-Bridge Interaction and Role in alpha 1b-Adrenergic Receptor Activation J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 440 - 448. [Abstract] [Full Text] |
||||
![]() |
J. E. Porter and D. M. Perez Characteristics for a Salt-bridge Switch Mutation of the alpha 1b Adrenergic Receptor. ALTERED PHARMACOLOGY AND RESCUE OF CONSTITUTIVE ACTIVITY J. Biol. Chem., December 3, 1999; 274(49): 34535 - 34538. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. J. Waugh, R. J. Gaivin, D. S. Damron, P. A. Murray, and D. M. Perez Binding, Partial Agonism, and Potentiation of alpha 1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1164 - 1171. [Abstract] [Full Text] |
||||
![]() |
S. Chen, M. Xu, F. Lin, D. Lee, P. Riek, and R. M. Graham Phe310 in Transmembrane VI of the alpha 1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding J. Biol. Chem., June 4, 1999; 274(23): 16320 - 16330. [Abstract] [Full Text] [PDF] |
||||